Molecular and Cellular Biochemistry

, Volume 252, Issue 1–2, pp 369–377

Effects of niacin-bound chromium, Maitake mushroom fraction SX and (–)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats

  • Nadeem Talpur
  • Bobby W. Echard
  • Taharat Yasmin
  • Debasis Bagchi
  • Harry G. Preuss


Previous studies in our laboratories have demonstrated that niacin-bound chromium (NBC), Maitake mushroom and (–)-hydroxycitric acid (HCA-SX) can ameliorate hypertension, dyslipidemias and diabetes mellitus, and therefore may be useful in weight management. In the present study, we used aged, diabetic Zucker fatty rats (ZFR) (70–75 weeks) in order to determine whether NBC, fraction SX of Maitake mushroom (MSX) and 60% (–)-hydroxycitric acid (HCA-SX) from Garcinia cambogia, alone or in combination, can affect certain aspects of the metabolic syndrome. Syndrome X or metabolic syndrome has been described as a concurrence of disturbed glucose and insulin metabolism, overweight and abdominal fat distribution, mild dyslipidemia, and hypertension, which are associated with subsequent development of type 2 diabetes mellitus and cardiovascular disease. Four groups of eight ZFR were gavaged daily with different supplements. For the initial three weeks, the control group of ZFR received only water, the second group received NBC 40 mcg elemental chromium/day, the third group received MSX 100 mg/day and the last group received HCA-SX 200 mg/day. During weeks 4–6, the doses of each treatment were doubled. The control animals lost approximately 50 g body weight (BW) per rat over 6 weeks of treatment, which is characteristic of these animals in declining health. In contrast, eight ZFR receiving NBC lost approximately 9 g BW per rat, while rats consuming MSX lost 16 g BW per rat. However, ZFR receiving HCA-SX simulated the pattern in the control group because these animals lost approximately 46 g BW per rat. The wide individual variations resulted in a lack of statistical significance among groups. Nevertheless, 75% of the ZFR in the control group lost more than 50 g BW over the 6 weeks duration, whereas none of the ZFR receiving NBC, 25% of the ZFR receiving MSX and 57% of the ZFR receiving HCA-SX lost over 50 g BW over the 6 weeks of the study. ZFR in all 3 treatment groups showed significantly lower blood pressures as compared to control, which seemed to be dose related. The general trend was for renal and liver blood parameters, hepatic and renal lipid peroxidation and DNA fragmentation to improve due to the supplementation of these natural products. Treatment of animals with a combination of these three novel supplements resulted in a lower SBP and maintenance of BW compared to control animals. These results demonstrate that elderly diabetics and even aging individuals might benefit from a similar regimen.

Metabolic Syndrome or Syndrome X aged obese Zucker rats niacin-bound chromium Maitake mushroom (–)-hydroxycitrate acid aging body weight SBP insulin resistance lipid peroxidation DNA damage 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Preuss HG: Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence. J Am Coll Nutr 16: 397-403, 1997Google Scholar
  2. 2.
    Preuss HG, Bagchi D, Clouatre D: Insulin resistance: A factor in aging. In: M.J. Ghen, N. Corso, H. Joiner-Bey, R. Klatz, A. Dratz (eds). The Advanced Guide to Longevity Medicine. Ghen, Landrum SC, 2001, pp 239-249Google Scholar
  3. 3.
    Yudkin J: Sucrose, coronary heart disease, diabetes, and obesity. Do hormones provide a link? Am Heart J 115: 493-498, 1988Google Scholar
  4. 4.
    Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988Google Scholar
  5. 5.
    Bray GA: The Zucker-fatty rat: A review. Fed Proc 36: 148-153, 1977Google Scholar
  6. 6.
    Bach A, Schirardin H, Bauer M, Schaeffer A, Weryha A: Age-related changes in biological parameters in Zucker rats. Lipids 16: 841-848, 1981Google Scholar
  7. 7.
    DeFronzo R: Glucose tolerance and aging. Diabetes Care 4: 493-501, 1981Google Scholar
  8. 8.
    Reaven GM, Chen N, Hollenbeck C, Chen YDI: Effect of age on glucose tolerance and glucose uptake in healthy individuals. J Am Geriatr Soc 37: 735-740, 1989Google Scholar
  9. 9.
    Broughton DL, Taylor RL: Review: deterioration of glucose tolerance with age: The role of insulin resistance. Age Ageing 20: 221-225, 1991Google Scholar
  10. 10.
    Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AW, Andres R: Age as independent determinant of glucose tolerance. Diabetes 40: 44-51, 1991Google Scholar
  11. 11.
    Mertz W: Chromium occurrence and function in biological systems. Physiol Rev 49: 163-239, 1969Google Scholar
  12. 12.
    Anderson RA: Chromium as an essential nutrient for humans. Regul Toxicol Pharmacol 26: S35-S41, 1997aGoogle Scholar
  13. 13.
    Anderson, RA: Nutritional factors influencing the glucose/insulin system: Chromium. J Am Coll Nutr 16: 404-410, 1997bGoogle Scholar
  14. 14.
    el Zein M, Areas JL, Preuss, HG: Long-term effects of excess sucrose ingestion on three strains of rats. Am J Hypertens 3: 560-562, 1990Google Scholar
  15. 15.
    Talpur N, Echard B, Dadgar A, Aggarwal S, Zhuang C, Bagchi D, Preuss HG: Effects of Maitake mushroom fractions on blood pressure of Zucker Fatty rats (submitted)Google Scholar
  16. 16.
    Clouatre D, Rosenbaum M: The Diet and Health Benefits of HCA. A Keats Good Health Guide, New Canaan, CT, 1994, p 9Google Scholar
  17. 17.
    Ohia SE, Opere CA, LeDay AM, Bagchi M, Bagchi D, Stohs SJ: Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Mol Cell Biochem 238: 89-103, 2002Google Scholar
  18. 18.
    Sullivan AC, Triscari J, Hamilton JG, Miller ON, Wheatley VR: Effect of (−)-hydroxycitrate upon the accumulation of lipid in the Rat. I. Lipogenesis. Lipids 9: 121-128, 1974Google Scholar
  19. 19.
    Sullivan AC, Triscari J, Hamilton JG, Miller ON: Effect of (−)-Hydroxycitrate upon the accumulation of lipid in the rat. II. Appetite. Lipids 9: 129-134, 1974Google Scholar
  20. 20.
    Sullivan AC, Hamilton JG, Miller ON, Wheatley VR: Inhibition of lipogenesis in rat liver by (−)-hydroxycitrate. Arch Biochem Biophys 150: 183-190, 1972Google Scholar
  21. 21.
    Vasselli JR, Shane E, Boozer CN, Heymsfield SB: Garcina Cambogia extract inhibits body weight gain via increased energy expenditure (EE) in rats. FASEB J 12: (abstr) 2938, 1998Google Scholar
  22. 22.
    Leonhardt M, Hrupka B, Langhans W: Effect of hydroxycitrate on food intake and body weight regain after a period of restrictive feeding in male rats. Physiol Behav 74: 191-196, 2001Google Scholar
  23. 23.
    Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK: Chemistry and biochemistry of (−)-hydroxycitric acid from Garcinia. J Agric Food Chem 50: 10-22, 2002Google Scholar
  24. 24.
    Bunag RD: Validation in awake rats of a tail-cuff method measuring systolic pressure. J Appl Physiol 34: 279-282, 1973Google Scholar
  25. 25.
    Talpur NA, Echard BW, Fan AY, Jaffari O, Bagchi D, Preuss HG: Antihypertensive and metabolic effects of whole Maitake mushroom powder and its fractions in two rat strains. Mol Cell Biochem 237: 129-136, 2002Google Scholar
  26. 26.
    Buege JA, Aust SD: Microsomal lipid peroxidation. Meth Enzymol 52: 302-310, 1978Google Scholar
  27. 27.
    Bagchi M, Hassoun EA, Bagchi D, Stohs SJ: Production of reactive oxygen species by peritoneal macrophages and hepatic mitochondria and microsomes from endrin-treated rats. Free Radic Biol Med 14: 149-155, 1993Google Scholar
  28. 28.
    Bagchi D, Vuchetich PJ, Bagchi M, Tran MX, Krohn RL, Ray SD, Stohs SJ: Protective effects of zinc salts on TPA-induced hepatic and brain lipid peroxidation, glutathione depletion, DNA damage and peritoncal macrophage activation in mice. Gen Pharmacol 30: 43-50, 1998Google Scholar
  29. 29.
    Dunnett C: A multiple comparison procedure for comparing several treatments with control. J Am Statis Assoc 50: 1096-1121, 1955Google Scholar
  30. 30.
    Masoro EJ, McCarter RJ, Katz MS, McMahan CA: Dietary restriction alters characteristics of glucose fuel use. J Gerontol 47: B202-B208, 1992Google Scholar
  31. 31.
    Walford RL, Harris SB, Gunion MW: The calorically restricted lowfat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol and blood pressure in humans. Proc Natl Acad Sci USA 89: 11533-11537, 1992Google Scholar
  32. 32.
    DeFronzo RA: Glucose intolerance and aging. Diabetes Care 4: 493-501, 1981Google Scholar
  33. 33.
    Yudkin J: Patterns and trends in carbohydrate consumption and their relation to disease. Proc Nutr Soc 23: 149-162, 1964Google Scholar
  34. 34.
    Yudkin J, Morland J: Sugar intake and myocardial infarction. Am J Clin Nutr 20: 503-506, 1964Google Scholar
  35. 35.
    Yudkin J, Szanto S: Hyperinsulinism and atherogenesis. Br Med J 1: 349, 1971Google Scholar
  36. 36.
    Olin KL, Stearns DM, Armstrong WH, Keen CL: Comparative retention/absorption of 51chromium (51Cr) from 51Cr chloride, 51Cr nicotinate and 51Cr picolinate in a rat model. Tr Elem Electr 11: 182-186, 1994Google Scholar
  37. 37.
    Lefavi RG, Wilson GD, Keith RE, Anderson RA, Blessing DL, Hames CG, McMillan JL: Lipid-lowering effect of a dietary chromium (III) nicotinic acid complex in male athletes. Nutr Res 13: 239-249, 1993Google Scholar
  38. 38.
    Preuss HG, Wallerstedt D, Talpur N, Tutuncuoglu SO, Echard B, Myers A, Bui M, Bagchi D: Effects of chromium and grape seed extract on the lipid profile of hypercholesterolemic subjects: A pilot study. J Med 31: 227-246, 2000Google Scholar
  39. 39.
    Preuss HG, Gondal JA, Bustos E, Bushehri N, Lieberman S, Bryden NA, Polansky MM, Anderson RA: Effects of chromium and guar on sugar-induced hypertension in rats. Clin Nephrol 44: 170-177, 1995Google Scholar
  40. 40.
    Preuss HG, Grojec PL, Lieberman S, Anderson RA: Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol 47: 325-330, 1997Google Scholar
  41. 41.
    Preuss HG, Montamarry S, Echard B, Scheckenbach R, Bagchi D: Long-term effects of chromium, grape seed extract, and zinc on various metabolic parameters of rats. Mol Cell Biochem 223: 95-102, 2001Google Scholar
  42. 42.
    Grant KE, Chandler RM, Castle AL, Ivy JL: Chromium and exercise training: Effect on obese women. Med Sci Sports Exer 29: 992-998, 1997Google Scholar
  43. 43.
    Crawford V, Scheckenbach R, Preuss HG: Effects of niacin-bound chromium supplementation on body composition in overweight African-American women. Diab Obes Metab 1: 331-337, 1999Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Nadeem Talpur
    • 1
  • Bobby W. Echard
    • 1
  • Taharat Yasmin
    • 2
  • Debasis Bagchi
    • 2
  • Harry G. Preuss
    • 1
  1. 1.Department of Physiology and BiophysicsGeorgetown University Medical CenterWashingtonUSA
  2. 2.Department of Pharmacy SciencesCreighton University Medical CenterOmahaUSA

Personalised recommendations